28S rRNA Expansion Segments Build Nucleolar Layers
2026-09-01
Wei et al. show that 28S rRNA expansion segments act as multivalent architectural elements that help generate multilayered nucleolar organization. Through comparative RNA analysis, in vitro reconstitution, segment deletion and transfer experiments, and simulations, the study connects evolutionary RNA expansion with the emergence of more complex nucleolar architecture.
Berberrubine chloride: Research Workflows
2026-08-31
Build reproducible cancer, metabolic, and thrombosis assays around Berberrubine chloride, from DMSO stock preparation to mechanism-linked readouts. The compound combines IMPDH2 and TrxR activity with urate-transporter and vitamin K pathway effects, enabling comparative workflows rather than single-endpoint screening.
Blebbistatin for Spatial Structure–Function Assays
2026-08-30
Discover how (±)-Blebbistatin can be used as a reversible perturbation tool for linking myosin II-dependent mechanics with cell migration, adhesion, and morphology. Inspired by panoramic cardiac structure–function mapping, this guide presents a spatially resolved strategy for designing and interpreting cytoskeletal assays.
Amitriptyline HCl in BBB Assay Design
2026-08-29
Explore how Amitriptyline HCl can function as an interpretive tool in CNS permeability studies, not merely as a receptor probe. This article applies a validated MOCK/MDR1 barrier framework and lysosomal-trapping correction to improve assay decisions in neuropharmacology research.
Cytochalasin D for Actin-Dependent Uptake Assays
2026-08-29
Cytochalasin D turns nanoparticle uptake studies from descriptive imaging experiments into functional tests of actin dependence. This workflow shows how to use controlled cytoskeletal perturbation alongside particle size, surface chemistry, viability, and morphology measurements in human corneal epithelial cell models.
Balsalazide for Active Ulcerative Colitis: Evidence
2026-08-28
The 2009 review by Wiggins and Rajapakse evaluates balsalazide as a colon-targeted 5-aminosalicylate prodrug, emphasizing bacterial azoreduction, remission induction, and comparative tolerability. Its main practical implication is that balsalazide can provide rapid, effective treatment for mild-to-moderate active ulcerative colitis while also offering a mechanistic framework for inflammation research.
mssVIM–IGF-1R Signaling in Cancer Metastasis
2026-08-28
This bioRxiv preprint identifies a macrophage-secreted, N-terminally truncated vimentin variant that promotes breast cancer cell migration through an IGF-1R–RSK–integrin αVβ6 axis. The work reframes vimentin processing as a tumor-microenvironment signaling event and provides a mechanistic basis for associating mssVIM with malignancy and lymph-node metastasis, while requiring further peer-reviewed validation.
Intravesical p21 mRNA–LNPs for Bladder Cancer
2026-08-27
The reference study develops chemically modified p21 mRNA packaged in lipid nanoparticles for catheter-based intravesical treatment of bladder cancer. Its data show localized p21 restoration, suppression of tumor-cell proliferation, and reduced tumor growth in an orthotopic mouse model, while also defining important translational questions about dosing, formulation, and clinical delivery.
Dihydroartemisinin Research Workflows
2026-08-27
Build more reproducible malaria, mTOR, and inflammation assays with a defined Artemisia-derived compound rather than a chemically variable extract. This guide covers stock preparation, washout designs, pathway readouts, comparative controls, and troubleshooting for Dihydroartemisinin research.
Triptolide (PG490): Transcription Meets Translation
2026-08-26
Triptolide (PG490) is more than a potent transcriptional inhibitor: it is a translational probe for studying how transcriptional stress, immune signaling, invasion, apoptosis, and genome stability intersect. This article connects triptolide’s CDK7–RNAPII activity with new findings on cell-cycle-controlled transcription condensates, then translates those insights into experimental design, biomarker selection, and preclinical decision-making.
BMS-777607: MET Signaling and Assay Design
2026-08-26
BMS-777607 is a selective c-Met inhibitor for dissecting MET signaling, tumor metastasis, and exploratory megakaryocyte assays. This article connects its kinase pharmacology with a 2026 hiPSC-derived platelet study while separating validated findings from hypothesis-generating applications.
TRIM21–ERK1/2 in Pituitary Tumor Resistance
2026-08-25
The reference study identifies TRIM21 as a context-dependent regulator of ERK1/2 signaling, pituitary adenoma proliferation, and dopamine-agonist resistance. Its combination of CRISPR screening, interaction proteomics, ubiquitination analysis, and drug screening nominates TRIM21 suppression—and compounds including Quisinostat—as a testable therapeutic strategy.
Phosbind Acrylamide: From Shift to Mechanism
2026-08-25
Phosbind Acrylamide converts phosphorylation-dependent mobility changes into a practical mechanistic readout for protein phosphorylation analysis. This article connects phosphate-affinity SDS-PAGE with the SmCPK20–SmWRKY2 jasmonate pathway and explains how to design, control, and interpret the assay.
Molidustat (BAY85-3934) HIF Study Workflow
2026-08-24
Molidustat (BAY85-3934) gives researchers a practical way to connect HIF stabilization with erythropoietin stimulation, renal anemia therapy, and hypoxic-cell assays. This workflow also uses a cardiomyocyte injury model to test whether pharmacologic HIF preservation can offset VHL-associated HIF-1α loss, while clearly separating established findings from exploratory applications.
BPN-19186: Reliable Cell Assay Workflows
2026-08-23
A practical, evidence-aware guide to using SKU A8959, also known as BPN-19186, in cell viability, proliferation, cytotoxicity, and pathway-focused experiments. It connects compound handling and controls with recent sEH–Nrf2–osteoclastogenesis findings while clearly separating established data from workflow recommendations.
464 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page